Polyhydroxyalkanoates – what are the uses? Current challenges and perspectives

References

• Adamus G, Sikorska W, Janeczek H, et al. (2012). Novel block copolymers of atactic PHB with natural PHA for cardiovascular engineering: synthesis and characterization. Europ Polym J, 48, 621–31
   Web of Science ®Google Scholar
• Akaraonye E, Keshavarz T, Roy I. (2010). Production of polyhydroxyalkanoates: the future green materials of choice. J Chem Technol Biotechnol, 85, 732–43
   Web of Science ®Google Scholar
• Armstrong SJ, Wiberg M, Terenghi G, Kingham PJ. (2007). ECM molecules mediate both Schwann cell proliferation and activation to enhance neurite outgrowth. Tissue Eng, 13, 2863–70
   PubMedGoogle Scholar
• Baek JY, Xing ZC, Kwak G, et al. (2012). Fabrication and characterization of collagen-immobilized porous PHBV/HA nanocomposite scaffolds for bone tissue engineering. J Nanomater, Article ID 171804, 1–11. doi:10.1155/2012/171804
   Web of Science ®Google Scholar
• Bian YZ, Wang Y, Guli S, et al. (2009). Evaluation of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) conduits for peripheral nerve regeneration. Biomaterials, 30, 217–25
   PubMed Web of Science ®Google Scholar
• Bruder SP, Fox BS. (1999). Tissue engineering of bone. Cell based strategies. Clin Orthop Relat Res, 367, 68–83
   PubMed Web of Science ®Google Scholar
• Chen GQ. (2009). A microbial polyhydroxyalkanoates (PHA) based bio and materials industry. Chem Soc Rev, 38, 2434–46
   PubMed Web of Science ®Google Scholar
• Chen W, Tong YW. (2012). PHBV microspheres as neural tissue engineering scaffold support neuronal cell growth and axon–dendrite polarization. Acta Biomaterialia, 8, 540–8
   PubMed Web of Science ®Google Scholar
• Chen GQ, Wu Q. (2005). Polyhydroxyalkanoates as tissue engineering materials. Biomaterials, 26, 6565–78
   PubMed Web of Science ®Google Scholar
• Chen GQ, Zhang G, Park SJ, Lee SJ. (2001). Industrial production of poly(hydroxybutyrate-co-hydroxyhexanoate). Appl Microbiol Biot, 57, 50–5
   PubMed Web of Science ®Google Scholar
• Chowdhury AA. (1963). Poly-β-hydroxybuttersaüre abbauende bakterien und exoenzyme. Arch Mikrobiol, 47, 167–200
   PubMedGoogle Scholar
• Cool SM, Kenny B, Wu A, et al. (2007). Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) composite biomaterials for bone tissue regeneration, in vitro performance assessed by osteoblast proliferation, osteoclast adhesion and resorption, and macrophage pro-inflammatory response. J Biomed Mater Res A, 82A, 599–610
   Web of Science ®Google Scholar
• Dai ZW, Zou XH, Chen GQ. (2009). Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) as an injectable implant system for prevention of post-surgical tissue adhesion. Biomaterials, 30, 3075–83
   PubMed Web of Science ®Google Scholar
• Dhandayuthapani B, Yoshida Y, Maekawa T, Kumar DS. (2011). Polymeric scaffolds in tissue engineering application: a review. Int J Polym Sci, Article ID 290602, 1–19. doi:10.1155/2011/290602
   Web of Science ®Google Scholar
• Du DJ, Furukawa KS, Ushida T. (2009). 3-D culture of osteoblast-like cells by unidirectional or oscillatory flow for bone tissue engineering. Biotechnol Bioeng, 102, 1670–8
   PubMed Web of Science ®Google Scholar
• Francis L, Meng D, Knowles J, et al. (2011). Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres. Int J Mol Sci, 12, 4294–314
   PubMed Web of Science ®Google Scholar
• Fu P, Sodian R, Luders C, et al. (2004). Effects of basic fibroblast growth factor and transforming growth factor-beta on maturation of human pediatric aortic cell culture for tissue engineering of cardiovascular structures. ASAIO J, 50, 9–14
   PubMed Web of Science ®Google Scholar
• Gabriel J. (2007). The biology of cancer. New York: John Wiley & Sons
   Google Scholar
• Gao Y, Kong L, Zhang L, et al. (2006). Improvement of mechanical properties of poly(dl-lactide) films by blending of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). Eur Polym J, 42, 764–75
   Web of Science ®Google Scholar
• Gaudio DC, Fioravanzo L, Folin M, et al. (2012). Electrospun tubular scaffolds: on the effectiveness of blending poly(e-caprolactone) with poly(3-hydroxybutyrate-co-3-hydroxyvalerate). J Biomed Mater Res Part B, 100B, 1883–98
   Web of Science ®Google Scholar
• Gursel I, Yagmurlu F, Korkusuz F, Hasirci V. (2002). In vitro antibiotic release from poly(3-hydroxybutyrate-co-3-hydroxyvalerate) rods. J Microencapsul, 19, 153–64
   PubMed Web of Science ®Google Scholar
• Hayati AN, Hosseinalipour SM, Rezaie HR, Shokrgozar MA. (2012). Characterization of poly(3-hydroxybutyrate)/nano-hydroxyapatite composite scaffolds fabricated without the use of organic solvents for bone tissue engineering application. Mater Sci Eng C, 32, 416–22
   Web of Science ®Google Scholar
• Jendrossek D. (2009). Polyhydroxyalkanoates granules complex sub-cellular organelles (carbosomes). J Bacteriol, 191, 3195–202
   PubMed Web of Science ®Google Scholar
• Ji Y, Li XT, Chen GQ. (2008). Interactions between a poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co- 3-hydroxyhexanoate) terpolyester and human keratinocytes. Biomaterials, 29, 3807–14
   PubMed Web of Science ®Google Scholar
• Karageorgiou V, Kaplan D. (2005). Porosity of 3-D biomaterial scaffolds and osteogenesis. Biomaterials, 26, 5474–91
   PubMed Web of Science ®Google Scholar
• Kılıçay E, Demirbilek M, Türk M, et al. (2011). Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Europ J Pharm Sci, 44, 310–20
   PubMed Web of Science ®Google Scholar
• Knowles JC. (2003). Phosphate based glasses for biomedical applications. J Mater Chem, 13, 2395–401
   Web of Science ®Google Scholar
• Kuppan P, Vasanthan KS, Sundaramurthi D, et al. (2011). Development of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) fibers for skin tissue engineering: effects of topography, mechanical, and chemical stimuli. Biomacromolecules, 12, 3156–65
   PubMed Web of Science ®Google Scholar
• Lemoigne M. (1926). Produit de déshydratation et de polymérization de l'acide β-oxybutyrique. Bull Soc Chim Biol, 8, 770–82
   Google Scholar
• Li H, Chang J. (2005). Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres. J Control Release, 107, 463–73
   PubMed Web of Science ®Google Scholar
• Li Z, Lin H, Ishii N, Chen GQ, Inoue Y. (2007). Study of enzymatic degradation of microbial copolyesters consisting of 3-hydroxybutyrate and medium-chain-length 3-hydroxyalkanoates. Polym Degrad Stab, 92, 1708–14
   Web of Science ®Google Scholar
• Li J, Yun H, Gong YD, et al. (2005). Effects of surface modification of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) on physicochemical properties and on interactions with MC3T3-E1 cells. J Biomed Mater Res A, 75, 985–98
   PubMed Web of Science ®Google Scholar
• Li XT, Zhang Y, Chen GQ. (2008). Nanofibrous polyhydroxyalkanoate matrices as cell growth supporting materials. Biomaterials, 29, 3720–8
   PubMed Web of Science ®Google Scholar
• Li C, Zhang J, Li Y, et al. (2013). Poly (l-lactide-co-caprolactone) scaffolds enhanced with poly (β-hydroxybutyrate-co-β-hydroxyvalerate) microspheres for cartilage regeneration. Biomed Mater, 8 025005, 1–8
   Web of Science ®Google Scholar
• Liu Q, Chen GQ. (2008). In vitro biocompatibility and degradation of terpolyester 3HB-co-4HB-co-3HHx, consisting of 3-hydroxybutyrate, 4-hydroxybutyrate and 3-hydroxyhexanoate. J Biomater Sci Polymer Ed, 9, 1521–33
   Google Scholar
• Liu J, Zhao B, Zhang Y, et al. (2010). PHBV and pre-differentiated human adipose-derived stem cells for cartilage tissue engineering. J Biomed Mater Res Part A, 94A, 603–10
   Web of Science ®Google Scholar
• Llombart A, Felipo V, Lopez-Guerrero JA, eds. (2006). New trends in cancer for the 21st century. New York: Springer
   Google Scholar
• Lobler M, SaX M, Schmitz KP, Hopt UT. (2003). Biomaterial implants induce the inflammation marker CRP at the site of implantation. J Biomed Mater Res, 61, 165–77
   Web of Science ®Google Scholar
• Lu XY, Zhang Y, Wang L. (2010). Preparation and in vitro drug-release behavior of 5-fluorouracil-loaded poly(hydroxybutyrate-co-hydroxyhexanoate) nanoparticles and microparticles. J Appl Polym Sci, 116, 2944–50
   Web of Science ®Google Scholar
• Lu XY, Ciraolo E, Stefenia R, et al. (2011). Sustained release of PI3K inhibitor from PHA nanoparticles and in vitro growth inhibition of cancer cell lines. Appl Microbiol Biotechnol, 89, 1423–33
   PubMed Web of Science ®Google Scholar
• Ma PX. (2004). Scaffold for tissue fabrication. Mater Today, 7, 30–40
   Web of Science ®Google Scholar
• Madison LL, Huisman GW. (1999). Metabolic engineering of poly(3-hydroxyalkanoates): from DNA to plastic. Microbiol Mol Biol Rev, 63, 21–53
   PubMed Web of Science ®Google Scholar
• Masaeli E, Morshed M, Nasr-Esfahani MH, Sadri S, Hilderink J, et al. (2013) Fabrication, Characterization and Cellular Compatibility of Poly(Hydroxy Alkanoate) Composite Nanofibrous Scaffolds for Nerve Tissue Engineering. PLoS ONE 8(2): e57157. doi:10.1371/journal.pone.0057157
   Google Scholar
• Masood F, Chen P, Fatima N, et al. (2013a). Encapsulation of ellipticine in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles and its in vitro application. Mater Sci Eng C, 33, 1054–60
   PubMed Web of Science ®Google Scholar
• Masood F, Chen P, Tariq Y, et al. (2013b). Synthesis of poly-(3-HB-co-12 mol% 3HV) by Bacillus cereus FB11, its characterization and application as a drug carrier. J Mater Sci: Mater Medi, 24, 1927–37
   PubMed Web of Science ®Google Scholar
• Mendes JBE, Riekes MK, Oliveira VM, et al. (2012). PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Scientific World J, Article ID 542937, 1–13
   Google Scholar
• Misra SK, Valappil SP, Roy I, Boccaccini AR. (2006). Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules, 7, 2249–58
   PubMed Web of Science ®Google Scholar
• Misra SK, Ansari TI, Valappil SP, et al. (2010). Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications. Biomaterials, 31, 2806–15
   PubMed Web of Science ®Google Scholar
• Mittal G, Sahana DK, Bhardwaj V, Kumar MNVR. (2007). Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. J Control Release, 119, 77–85
   PubMed Web of Science ®Google Scholar
• Mohanna PN, Young RC, Wiberg M, Terenghi G. (2003). A composite poly-hydroxybutyrate–glial growth factor conduit for long nerve gap repairs. J Anat, 203, 553–65
   PubMed Web of Science ®Google Scholar
• Mukai K, Doi Y, Sema Y, Tomita K. (1993). Substrate specificities in hydrolysis of polyhydroxyalkanoates by microbial esterases. Biotechnol Lett, 15, 601–4
   Web of Science ®Google Scholar
• Numata K, Yamashita K, Fujita M, et al. (2007). Adsorption and hydrolysis reactions of poly(hydroxybutyric acid) depolymerases secreted from Ralstonia pickettii T1 and Penicillium funiculosum onto poly[(R)-3-hydroxybutyric acid]. Biomacromolecules, 8, 2276–81
   PubMed Web of Science ®Google Scholar
• Ojumu TV, Yu J, Solomon BO. (2004). Production of polyhydroxyalkonates, a bacterial biodegradable polymer. Afri J Biotechnol, 3, 18–24
   Google Scholar
• Peng SW, Guo XY, Shang GG, et al. (2011). An assessment of the risks of carcinogenicity associated with polyhydroxyalkanoates through an analysis of DNA aneuploid and telomerase activity. Biomaterials, 32, 2546–55
   PubMed Web of Science ®Google Scholar
• Phithakrotchanakoon C, Rudeekit Y, Tanapongpipat S, et al. (2009). Microbial degradation and physico-chemical alteration of polyhydroxyalkanoates by a thermophilic Streptomyces sp. Biologia, 64, 246–51
   Web of Science ®Google Scholar
• Pignatello R, Musumecia T, Impallomeni G, et al. (2009). Poly(3-hydroxybutyrate-co-ɛ-caprolactone) copolymers and poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-ɛ-caprolactone) terpolymers as novel materials for colloidal drug delivery systems. Eur J Pharm Sci, 37, 451–62
   PubMed Web of Science ®Google Scholar
• Polyhydroxyalkanoate (PHA) market worth 34 000 MT By 2018. Available from: http://online.wsj.com/article/PR-CO-20130430-908358.html [last accessed 19 Jun 2013]
   Google Scholar
• Pötter M, Steinbüchel A. (2005). Poly (3-hydroxybutyrate) granule-associated proteins: impacts on poly (3-hydroxybutyrate) synthesis and degradation. Biomacromolecules, 6, 552–60
   PubMed Web of Science ®Google Scholar
• Prabhakaran MP, Vatankhah E, Ramakrishna S. (2013). Electrospun aligned PHBV/collagen nanofibers as substrates for nerve tissue engineering. Biotechnol Bioeng, 110 (10), 2775–84, doi 10.1002/bit.24937
   Google Scholar
• Qu XH, Wu Q, Chen GQ. (2006). In vitro study on hemocompatibility and cytocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). J Biomater Sci, 17, 1107–21
   Web of Science ®Google Scholar
• Qu XH, Wu Q, Liang J, et al. (2005). Enhanced vascular-related cellular affinity on surface modified copolyesters of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx). Biomaterials, 26, 6991–7001
   PubMed Web of Science ®Google Scholar
• Reddy CS, Ghai R, Rashmi, Kalia VC. (2003). Polyhydroxyalkanoates: an overview. Bioresource Technol, 87, 13746 (Author initial is not given and available in the original paper)
   Google Scholar
• Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. (2006). Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnol Biol Med, 2, 8–21
   PubMed Web of Science ®Google Scholar
• Sankar D, Chennazhi KP, Nair SV, Jayakumar R. (2012). Fabrication of chitin/poly(3-hydroxybutyrate-co-3-hydroxyvalerate) hydrogel scaffold. Carbohyd Polym, 90, 725–9
   PubMed Web of Science ®Google Scholar
• Shah M, Naseer MI, Choi MH, et al. (2010). Amphiphilic PHA–mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. Int J Pharm, 400, 165–75
   PubMed Web of Science ®Google Scholar
• Shah M, Ullah N, Choi MH, et al. (2012). Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation. Europ J Pharm Biopharm, 80, 518–27
   PubMed Web of Science ®Google Scholar
• Shishatskaya EI, Volova TG. (2004). A comparative investigation of biodegradable polyhydroxyalkanoate films as matrices for in vitro cell cultures. J Mater Sci Mater Med, 15, 915–23
   PubMed Web of Science ®Google Scholar
• Sodian R, Hoerstrup SP, Sperling JS, et al. (2000a). Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg, 70, 140–4
   PubMed Web of Science ®Google Scholar
• Sodian R, Hoerstrup SP, Sperling JS, et al. (2000b). Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation, 102, III-22–9
   Web of Science ®Google Scholar
• Stamm C, Khosravi A, Grabow N, et al. (2004). Biomatrix/polymer composite material for heart valve tissue engineering. Ann Thorac Surg, 78, 2084–93
   PubMed Web of Science ®Google Scholar
• Sultana N. (2012). Production and characterization of tissue engineering scaffolds based on polyhydroxybutyrate-co-hydroxyvalerate polymers. International Conference on Biomedical Engineering (ICoBE); 2012; Penang
   Google Scholar
• Sun JY, Wu J, Li HY, Chang J. (2005). Macroporous poly(3-hydroxybutyrate-co-3-hydroxyvalerate) matrices for cartilage tissue engineering. Eur Polym J, 41, 2443–9
   Web of Science ®Google Scholar
• Tang HY, Ishii D, Mahara A, et al. (2008). Scaffolds from electrospun polyhydroxyalkanoate copolymers: fabrication, characterization, bioabsorption and tissue response. Biomaterials, 29, 1307–17
   PubMed Web of Science ®Google Scholar
• Veleirinho B, Coelho DS, Dias PF, et al. (2012). Nanofibrous poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/chitosan scaffolds for skin regeneration. Int J Biol Macromol, 51, 343–50
   PubMed Web of Science ®Google Scholar
• Volova T, Shishatskaya E, Sevastianov V, et al. (2003). Results of biomedical investigations of PHB and PHB/PHV fibers. Biochem Eng J, 16, 125–33
   Web of Science ®Google Scholar
• Wang Y, Bian YZ, Wu Q, Chen GQ. (2008). Evaluation of three-dimensional scaffolds prepared from poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for growth of allogeneic chondrocytes for cartilage repair in rabbits. Biomaterials, 29, 2858–68
   PubMed Web of Science ®Google Scholar
• Wang A, Gan Y, Qu J, et al. (2012). Application of electrospun poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate]-Ecoflex mats in periodontal regeneration: a primary study. Macau, Macao. International Conference on Biomedical Engineering and Biotechnology; 2012; 972–5
   Google Scholar
• Wang YW, Wu Q, Chen GQ. (2004). Attachment, proliferation and differentiation of osteoblasts on random biopolyester poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds. Biomaterials, 25, 669–75
   PubMed Web of Science ®Google Scholar
• Wang N, Zhou Z, Xia L, et al. (2013). Fabrication and characterization of bioactive β-Ca2SiO4/PHBV composite scaffolds. Mater Sci Eng C, 33, 2294–301
   PubMed Web of Science ®Google Scholar
• Williams SF, Martin DP, Horowitz DM, Peoples OP. (1999). PHA applications: addressing the price performance issue: I. Tissue engineering. Int J Biol Macromol, 25, 111–21
   PubMed Web of Science ®Google Scholar
• Wu TP, Hu P, Zhang XB, et al. (2004). Biocompatibility of modified poly-betahydroxybutyric acid to adrenocortical cells. J Wuhan Univ Technol Mater Sci, 19, 38–40
   Web of Science ®Google Scholar
• Wu S, Liu YL, Cui B, et al. (2007). Study on decellularized porcine aortic valve/poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) hybrid heart valve in sheep model. Artif Organs, 31, 689–97
   PubMed Web of Science ®Google Scholar
• Wu S, Liu Y, Cui B, et al. (2008). Intravascular biocompatibility of Poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) for cardiovascular tissue engineering. Chinese J Biotechnol, 24, 610–16
   Google Scholar
• Xiao XQ, Zhao Y, Chen GQ. (2007). The effect of 3-hydroxybutyrate and its derivatives on the growth of glial cells. Biomaterials, 28, 3608–16
   PubMed Web of Science ®Google Scholar
• Xiong YC, Yao YC, Zhan XY, Chen GQ. (2010). Application of polyhydroxyalkanoates nanoparticles as intracellular sustained drug-release vectors. J Biomater Sci, 21, 127–40
   PubMed Web of Science ®Google Scholar
• Yang M, Zhu S, Chen Y, et al. (2004). Studies on bone marrow stromal cells affinity of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). Biomaterials, 25, 1365–73
   PubMed Web of Science ®Google Scholar
• Yao YC, Zhan XY, Zou XH, et al. (2008). A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials, 29, 4823–30
   PubMed Web of Science ®Google Scholar
• Ye C, Hub P, Mac MX, et al. (2009). PHB/PHBHHx scaffolds and human adipose-derived stem cells for cartilage tissue engineering. Biomaterials, 30, 4401–6
   PubMed Web of Science ®Google Scholar
• Young RC, Wiberg M, Terenghi G. (2002). Poly-3-hydroxybutyrate (PHB): a resorbable conduit for long-gap repair in peripheral nerves. Br J Plast Surg, 55, 235–40
   PubMedGoogle Scholar
• Yu GH, Fan YB. (2008). Preparation of poly(d,l-lactic acid) scaffolds using alginate particles. J Biomater Sci-Polym Ed, 19, 87–98
   PubMed Web of Science ®Google Scholar
• Yucel D, Kose GT, Hasirci V. (2010). Polyester based nerve guidance conduit design. Biomaterials, 31, 1596–603
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhao LQ, Dong YF, et al. (2010). Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Eur J Pharm Biopharm, 76, 10–16
   PubMed Web of Science ®Google Scholar
• Zhang L, Zheng Z, Xi J, et al. (2007). Improved mechanical property and biocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for blood vessel tissue engineering by blending with poly(propylene carbonate). Europ Polym J, 43, 2975–86
   Web of Science ®Google Scholar
• Zhu XH, Gan SK, Wang CH, Tong YW. (2007a). Proteins combination on PHBV microsphere scaffold to regulate Hep3B cells activity and functionality: a model of liver tissue engineering system. J Biomed Mater Res, 83A, 606–16
   Web of Science ®Google Scholar
• Zhu XH, Wang CH, Tong YW. (2007b). Growing tissue-like constructs with Hep3B/HepG2 liver cells on PHBV microspheres of different sizes. J Biomed Mater Res B, 82B, 7–16
   Web of Science ®Google Scholar
• Zhu XH, Wang CH, Tong YW. (2009). In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. Biomed Mater Res, 89A, 411–23
   Web of Science ®Google Scholar